.Regeneron is actually back with lasting consequence for its LAG-3 prevention and PD-1 inhibitor com...
.AstraZeneca has actually discussed a very early examine the efficiency of its internal antibody-dru...
.After declaring a period 3 launch based upon beneficial midstage results, iTeos and also GSK are ac...
.The FDA needs to be even more open and collective to discharge a rise in commendations of rare ailm...
.It's an abnormally hectic Friday for biotech IPOs, along with Zenas BioPharma, MBX and Bicara Thera...
.Atea Pharmaceuticals' antiviral has actually fallen short one more COVID-19 test, however the biote...
.Neurocrine Biosciences' mental illness program pivot has neglected. The biotech was actually incapa...
.Sanofi has actually created an overdue entry to the radioligand party, paying one hundred million e...
.After F2G's 1st attempt to receive a new course of antifungal to market was hindered by the FDA, th...
.Moderna has actually vowed to reduce R&D spending by $1.1 billion by 2027. The choice to shrink ...